Atopic dermatitis: Melatonin as potential treatment

L. Marseglia, C. Cuppari, S. Manti, G. D'Angelo, C. Salpietro, Russel J Reiter, E. Gitto

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a chronic relapsing-remitting inflammatory skin disorder, characterized by a skin barrier dysfunction resulting in epidermal damage and altered permeability to allergens and microbes. Traditionally, the immunological mechanism involving the Th1-Th2 paradigm is considered central in the pathogenesis of AD. However, oxidative stress is, currently, recognized as a fundamental predisposing stimulus for AD. Several therapeutic approaches have been proposed as treatment, including the use of melatonin. This indolamine, through widespread expression and pleiotropic activity of the cutaneous melatoninergic system, may counteract environmental and endogenous stressors, regulate the immune response, decrease oxidative stress, and, finally, promote skin integrity. In the light of its pleiotropic effects, melatonin could represent a potential and alternative therapeutic approach in patients with AD.

Original languageEnglish (US)
Pages (from-to)142-149
Number of pages8
JournalJournal of Biological Regulators and Homeostatic Agents
Volume29
Issue number2
StatePublished - 2015

Fingerprint

Melatonin
Atopic Dermatitis
Skin
Oxidative Stress
Therapeutics
Allergens
Permeability

Keywords

  • Atopic dermatitis
  • Immunity
  • Melatonin
  • Oxidative stress

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Physiology
  • Immunology
  • Medicine(all)
  • Oncology
  • Endocrinology
  • Physiology (medical)
  • Cancer Research

Cite this

Marseglia, L., Cuppari, C., Manti, S., D'Angelo, G., Salpietro, C., Reiter, R. J., & Gitto, E. (2015). Atopic dermatitis: Melatonin as potential treatment. Journal of Biological Regulators and Homeostatic Agents, 29(2), 142-149.

Atopic dermatitis : Melatonin as potential treatment. / Marseglia, L.; Cuppari, C.; Manti, S.; D'Angelo, G.; Salpietro, C.; Reiter, Russel J; Gitto, E.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 29, No. 2, 2015, p. 142-149.

Research output: Contribution to journalArticle

Marseglia, L, Cuppari, C, Manti, S, D'Angelo, G, Salpietro, C, Reiter, RJ & Gitto, E 2015, 'Atopic dermatitis: Melatonin as potential treatment', Journal of Biological Regulators and Homeostatic Agents, vol. 29, no. 2, pp. 142-149.
Marseglia L, Cuppari C, Manti S, D'Angelo G, Salpietro C, Reiter RJ et al. Atopic dermatitis: Melatonin as potential treatment. Journal of Biological Regulators and Homeostatic Agents. 2015;29(2):142-149.
Marseglia, L. ; Cuppari, C. ; Manti, S. ; D'Angelo, G. ; Salpietro, C. ; Reiter, Russel J ; Gitto, E. / Atopic dermatitis : Melatonin as potential treatment. In: Journal of Biological Regulators and Homeostatic Agents. 2015 ; Vol. 29, No. 2. pp. 142-149.
@article{dbc4048796304360a82a2ef737701801,
title = "Atopic dermatitis: Melatonin as potential treatment",
abstract = "Atopic dermatitis (AD) is a chronic relapsing-remitting inflammatory skin disorder, characterized by a skin barrier dysfunction resulting in epidermal damage and altered permeability to allergens and microbes. Traditionally, the immunological mechanism involving the Th1-Th2 paradigm is considered central in the pathogenesis of AD. However, oxidative stress is, currently, recognized as a fundamental predisposing stimulus for AD. Several therapeutic approaches have been proposed as treatment, including the use of melatonin. This indolamine, through widespread expression and pleiotropic activity of the cutaneous melatoninergic system, may counteract environmental and endogenous stressors, regulate the immune response, decrease oxidative stress, and, finally, promote skin integrity. In the light of its pleiotropic effects, melatonin could represent a potential and alternative therapeutic approach in patients with AD.",
keywords = "Atopic dermatitis, Immunity, Melatonin, Oxidative stress",
author = "L. Marseglia and C. Cuppari and S. Manti and G. D'Angelo and C. Salpietro and Reiter, {Russel J} and E. Gitto",
year = "2015",
language = "English (US)",
volume = "29",
pages = "142--149",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife SAS",
number = "2",

}

TY - JOUR

T1 - Atopic dermatitis

T2 - Melatonin as potential treatment

AU - Marseglia, L.

AU - Cuppari, C.

AU - Manti, S.

AU - D'Angelo, G.

AU - Salpietro, C.

AU - Reiter, Russel J

AU - Gitto, E.

PY - 2015

Y1 - 2015

N2 - Atopic dermatitis (AD) is a chronic relapsing-remitting inflammatory skin disorder, characterized by a skin barrier dysfunction resulting in epidermal damage and altered permeability to allergens and microbes. Traditionally, the immunological mechanism involving the Th1-Th2 paradigm is considered central in the pathogenesis of AD. However, oxidative stress is, currently, recognized as a fundamental predisposing stimulus for AD. Several therapeutic approaches have been proposed as treatment, including the use of melatonin. This indolamine, through widespread expression and pleiotropic activity of the cutaneous melatoninergic system, may counteract environmental and endogenous stressors, regulate the immune response, decrease oxidative stress, and, finally, promote skin integrity. In the light of its pleiotropic effects, melatonin could represent a potential and alternative therapeutic approach in patients with AD.

AB - Atopic dermatitis (AD) is a chronic relapsing-remitting inflammatory skin disorder, characterized by a skin barrier dysfunction resulting in epidermal damage and altered permeability to allergens and microbes. Traditionally, the immunological mechanism involving the Th1-Th2 paradigm is considered central in the pathogenesis of AD. However, oxidative stress is, currently, recognized as a fundamental predisposing stimulus for AD. Several therapeutic approaches have been proposed as treatment, including the use of melatonin. This indolamine, through widespread expression and pleiotropic activity of the cutaneous melatoninergic system, may counteract environmental and endogenous stressors, regulate the immune response, decrease oxidative stress, and, finally, promote skin integrity. In the light of its pleiotropic effects, melatonin could represent a potential and alternative therapeutic approach in patients with AD.

KW - Atopic dermatitis

KW - Immunity

KW - Melatonin

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84981186414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981186414&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84981186414

VL - 29

SP - 142

EP - 149

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 2

ER -